909 related articles for article (PubMed ID: 15837815)
21. Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells.
Pusic I; DiPersio JF
Curr Opin Hematol; 2010 Jul; 17(4):319-26. PubMed ID: 20473162
[TBL] [Abstract][Full Text] [Related]
22. The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor.
Pelus LM; Bian H; Fukuda S; Wong D; Merzouk A; Salari H
Exp Hematol; 2005 Mar; 33(3):295-307. PubMed ID: 15730853
[TBL] [Abstract][Full Text] [Related]
23. Plerixafor: A chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation after high-dose chemotherapy for non-Hodgkin's lymphoma or multiple myeloma.
Steinberg M; Silva M
Clin Ther; 2010 May; 32(5):821-43. PubMed ID: 20685493
[TBL] [Abstract][Full Text] [Related]
24. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist.
Liles WC; Broxmeyer HE; Rodger E; Wood B; Hübel K; Cooper S; Hangoc G; Bridger GJ; Henson GW; Calandra G; Dale DC
Blood; 2003 Oct; 102(8):2728-30. PubMed ID: 12855591
[TBL] [Abstract][Full Text] [Related]
25. New agents for mobilizing peripheral blood stem cells.
Greinix HT; Worel N
Transfus Apher Sci; 2009 Aug; 41(1):67-71. PubMed ID: 19615944
[TBL] [Abstract][Full Text] [Related]
26. Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells.
Dar A; Schajnovitz A; Lapid K; Kalinkovich A; Itkin T; Ludin A; Kao WM; Battista M; Tesio M; Kollet O; Cohen NN; Margalit R; Buss EC; Baleux F; Oishi S; Fujii N; Larochelle A; Dunbar CE; Broxmeyer HE; Frenette PS; Lapidot T
Leukemia; 2011 Aug; 25(8):1286-1296. PubMed ID: 21494253
[TBL] [Abstract][Full Text] [Related]
27. The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by "on-demand" addition of plerixafor to granulocyte-colony-stimulating factor.
Girbl T; Lunzer V; Greil R; Namberger K; Hartmann TN
Transfusion; 2014 Sep; 54(9):2325-35. PubMed ID: 24673458
[TBL] [Abstract][Full Text] [Related]
28. Improved mobilization of peripheral blood CD34+ cells and dendritic cells by AMD3100 plus granulocyte-colony-stimulating factor in non-Hodgkin's lymphoma patients.
Gazitt Y; Freytes CO; Akay C; Badel K; Calandra G
Stem Cells Dev; 2007 Aug; 16(4):657-66. PubMed ID: 17784839
[TBL] [Abstract][Full Text] [Related]
29. Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells.
Uy GL; Rettig MP; Cashen AF
Expert Opin Biol Ther; 2008 Nov; 8(11):1797-804. PubMed ID: 18847313
[TBL] [Abstract][Full Text] [Related]
30. A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study.
Fruehauf S; Veldwijk MR; Seeger T; Schubert M; Laufs S; Topaly J; Wuchter P; Dillmann F; Eckstein V; Wenz F; Goldschmidt H; Ho AD; Calandra G
Cytotherapy; 2009; 11(8):992-1001. PubMed ID: 19929463
[TBL] [Abstract][Full Text] [Related]
31. Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis.
Theiss HD; Vallaster M; Rischpler C; Krieg L; Zaruba MM; Brunner S; Vanchev Y; Fischer R; Gröbner M; Huber B; Wollenweber T; Assmann G; Mueller-Hoecker J; Hacker M; Franz WM
Stem Cell Res; 2011 Nov; 7(3):244-55. PubMed ID: 21752744
[TBL] [Abstract][Full Text] [Related]
32. Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation.
Winkler IG; Pettit AR; Raggatt LJ; Jacobsen RN; Forristal CE; Barbier V; Nowlan B; Cisterne A; Bendall LJ; Sims NA; Lévesque JP
Leukemia; 2012 Jul; 26(7):1594-601. PubMed ID: 22266913
[TBL] [Abstract][Full Text] [Related]
33. Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4F-benzoyl-TN14003.
Abraham M; Biyder K; Begin M; Wald H; Weiss ID; Galun E; Nagler A; Peled A
Stem Cells; 2007 Sep; 25(9):2158-66. PubMed ID: 17525235
[TBL] [Abstract][Full Text] [Related]
34. Plerixafor (AMD3100) induces prolonged mobilization of acute lymphoblastic leukemia cells and increases the proportion of cycling cells in the blood in mice.
Welschinger R; Liedtke F; Basnett J; Dela Pena A; Juarez JG; Bradstock KF; Bendall LJ
Exp Hematol; 2013 Mar; 41(3):293-302.e1. PubMed ID: 23178377
[TBL] [Abstract][Full Text] [Related]
35. [Effects of the mobilization with AMD3100, granulocyte-colony-stimulating factor (G-CSF) alone and in combination on the immunological function of the lymphocytes in mice].
Kong Y; Feng R; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):358-61. PubMed ID: 22781791
[TBL] [Abstract][Full Text] [Related]
36. The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristics.
Fruehauf S; Seeger T; Maier P; Li L; Weinhardt S; Laufs S; Wagner W; Eckstein V; Bridger G; Calandra G; Wenz F; Zeller WJ; Goldschmidt H; Ho AD
Exp Hematol; 2006 Aug; 34(8):1052-9. PubMed ID: 16863911
[TBL] [Abstract][Full Text] [Related]
37. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide.
Lévesque JP; Hendy J; Takamatsu Y; Simmons PJ; Bendall LJ
J Clin Invest; 2003 Jan; 111(2):187-96. PubMed ID: 12531874
[TBL] [Abstract][Full Text] [Related]
38. Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC chemokine GRObeta.
King AG; Horowitz D; Dillon SB; Levin R; Farese AM; MacVittie TJ; Pelus LM
Blood; 2001 Mar; 97(6):1534-42. PubMed ID: 11238087
[TBL] [Abstract][Full Text] [Related]
39. Mobilization of progenitor cells into peripheral blood by gamma-tocotrienol: a promising radiation countermeasure.
Ray S; Kulkarni SS; Chakraborty K; Pessu R; Hauer-Jensen M; Kumar KS; Ghosh SP
Int Immunopharmacol; 2013 Mar; 15(3):557-64. PubMed ID: 23415908
[TBL] [Abstract][Full Text] [Related]
40. Autophagy is required for stem cell mobilization by G-CSF.
Leveque-El Mouttie L; Vu T; Lineburg KE; Kuns RD; Bagger FO; Teal BE; Lor M; Boyle GM; Bruedigam C; Mintern JD; Hill GR; MacDonald KP; Lane SW
Blood; 2015 May; 125(19):2933-6. PubMed ID: 25788702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]